SUN-627 for Non-Active Secondary and Primary Progressive MS
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Age
- 18 – 70
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Sundance Biosciences, Inc. · Industry
This trial is looking for men and women aged 18-70 with non-active secondary progressive or primary progressive multiple sclerosis. Participants will take part in studying the safety of a medication called SUN-627 and will need to meet certain health criteria.
You may be able to join if
- I am aged 18-70.
- I have been diagnosed with primary progressive MS or non-active secondary progressive MS.
- I have had no MS relapses in the past 2 years.
- I have evidence that my MS has been getting worse over time.
- I have a level of disability that fits the study requirements.
You may not be able to join if
- I am taking certain medications that are not allowed in this study.
- I am currently in another research study.
- I have certain heart conditions that may increase risk.
- I have serious medical conditions that could make the study unsafe.
- I have an active infection or a history of repeated infections.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe goal of this Phase 2 clinical trial is to investigate the safety and tolerability of SUN-627 in men and women aged 18-70 years old with a diagnosis of non-active SPMS/PPMS.
Loading trial locations…